Literature DB >> 30947113

Associations between baseline amyloid, sex, and APOE on subsequent tau accumulation in cerebrospinal fluid.

Rachel F Buckley1, Elizabeth C Mormino2, Jasmeer Chhatwal3, Aaron P Schultz4, Jennifer S Rabin5, Dorene M Rentz3, Diler Acar6, Michael J Properzi7, Julien Dumurgier7, Heidi Jacobs8, Teresa Gomez-Isla9, Keith A Johnson10, Reisa A Sperling3, Bernard J Hanseeuw11.   

Abstract

We investigated the effect of baseline Aβ, sex, and APOE on longitudinal tau accumulation in cerebrospinal fluid (CSF) in clinically normal older adults. Two hundred thirty-nine participants (aged 56-89 years, clinical dementia rating = 0) underwent serial CSF collection for Aβ1-42, total-tau (t-tau) and phospho-tau181P (p-tau). We used preprocessed data from fully automated Roche Elecsys immunoassays. A series of linear regressions were used to examine cross-sectional effects of Aβ1-42, sex, and APOEε4 on baseline CSF tau and linear mixed models for longitudinal changes in CSF tau. Cross-sectionally, CSF t-tau and p-tau were associated with abnormal Aβ1-42 and APOEε4 but not with sex. Longitudinally, low baseline CSF Aβ1-42 levels, but not APOEε4 or sex, predicted faster p-tau accumulation. The relationship between baseline CSF Aβ1-42 and tau accumulation was strongest in APOEε4 carriers, and particularly female carriers, relative to other groups. The current findings support an association between baseline CSF Aβ1-42 and changes in CSF tau. Elevated risk in females, apparent only in carriers, reinforces findings of sex-related vulnerability in those with genetic predisposition for Alzheimer's disease.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  APOE; Alzheimer's disease; Amyloid; Cerebrospinal fluid; Sex; tau

Mesh:

Substances:

Year:  2019        PMID: 30947113      PMCID: PMC6545139          DOI: 10.1016/j.neurobiolaging.2019.02.019

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  39 in total

1.  APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Authors:  John C Morris; Catherine M Roe; Chengjie Xiong; Anne M Fagan; Alison M Goate; David M Holtzman; Mark A Mintun
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

2.  Phases of Hyperconnectivity and Hypoconnectivity in the Default Mode and Salience Networks Track with Amyloid and Tau in Clinically Normal Individuals.

Authors:  Aaron P Schultz; Jasmeer P Chhatwal; Trey Hedden; Elizabeth C Mormino; Bernard J Hanseeuw; Jorge Sepulcre; Willem Huijbers; Molly LaPoint; Rachel F Buckley; Keith A Johnson; Reisa A Sperling
Journal:  J Neurosci       Date:  2017-03-17       Impact factor: 6.167

3.  The impact of amyloid-beta and tau on prospective cognitive decline in older individuals.

Authors:  Reisa A Sperling; Elizabeth C Mormino; Aaron P Schultz; Rebecca A Betensky; Kathryn V Papp; Rebecca E Amariglio; Bernard J Hanseeuw; Rachel Buckley; Jasmeer Chhatwal; Trey Hedden; Gad A Marshall; Yakeel T Quiroz; Nancy J Donovan; Jonathan Jackson; Jennifer R Gatchel; Jennifer S Rabin; Heidi Jacobs; Hyun-Sik Yang; Michael Properzi; Dylan R Kirn; Dorene M Rentz; Keith A Johnson
Journal:  Ann Neurol       Date:  2019-01-21       Impact factor: 10.422

4.  Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons.

Authors:  Michael C Donohue; Reisa A Sperling; Ronald Petersen; Chung-Kai Sun; Michael W Weiner; Paul S Aisen
Journal:  JAMA       Date:  2017-06-13       Impact factor: 56.272

5.  Fluorodeoxyglucose metabolism associated with tau-amyloid interaction predicts memory decline.

Authors:  Bernard J Hanseeuw; Rebecca A Betensky; Aaron P Schultz; Kathryn V Papp; Elizabeth C Mormino; Jorge Sepulcre; John S Bark; Danielle M Cosio; Molly LaPoint; Jasmeer P Chhatwal; Dorene M Rentz; Reisa A Sperling; Keith A Johnson
Journal:  Ann Neurol       Date:  2017-04-06       Impact factor: 10.422

6.  Amyloid-β--associated clinical decline occurs only in the presence of elevated P-tau.

Authors:  Rahul S Desikan; Linda K McEvoy; Wesley K Thompson; Dominic Holland; James B Brewer; Paul S Aisen; Reisa A Sperling; Anders M Dale
Journal:  Arch Neurol       Date:  2012-06

7.  Cerebrospinal fluid levels of amyloid beta-protein in Alzheimer's disease: inverse correlation with severity of dementia and effect of apolipoprotein E genotype.

Authors:  R M Nitsch; G W Rebeck; M Deng; U I Richardson; M Tennis; D B Schenk; C Vigo-Pelfrey; I Lieberburg; R J Wurtman; B T Hyman
Journal:  Ann Neurol       Date:  1995-04       Impact factor: 10.422

8.  Amyloid and APOE ε4 interact to influence short-term decline in preclinical Alzheimer disease.

Authors:  Elizabeth C Mormino; Rebecca A Betensky; Trey Hedden; Aaron P Schultz; Andrew Ward; Willem Huijbers; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  Neurology       Date:  2014-04-18       Impact factor: 9.910

9.  Technical performance of a novel, fully automated electrochemiluminescence immunoassay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid.

Authors:  Tobias Bittner; Henrik Zetterberg; Charlotte E Teunissen; Richard E Ostlund; Michael Militello; Ulf Andreasson; Isabelle Hubeek; David Gibson; David C Chu; Udo Eichenlaub; Peter Heiss; Uwe Kobold; Andreas Leinenbach; Kairat Madin; Ekaterina Manuilova; Christina Rabe; Kaj Blennow
Journal:  Alzheimers Dement       Date:  2015-11-10       Impact factor: 21.566

10.  APOE genotype and early β-amyloid accumulation in older adults without dementia.

Authors:  Yen Ying Lim; Elizabeth C Mormino
Journal:  Neurology       Date:  2017-08-09       Impact factor: 9.910

View more
  22 in total

Review 1.  Consideration of Sex Differences in the Measurement and Interpretation of Alzheimer Disease-Related Biofluid-Based Biomarkers.

Authors:  Michelle M Mielke
Journal:  J Appl Lab Med       Date:  2020-01-01

2.  Causal links among amyloid, tau, and neurodegeneration.

Authors:  Murat Bilgel; Dean F Wong; Abhay R Moghekar; Luigi Ferrucci; Susan M Resnick
Journal:  Brain Commun       Date:  2022-07-25

3.  Sex differences in Alzheimer's disease: do differences in tau explain the verbal memory gap?

Authors:  Sarah J Banks; Murray J Andrews; Leonardino Digma; John Madsen; Emilie T Reas; Jessica Z K Caldwell; Linda K McEvoy; Chun Chieh Fan; Anders M Dale; James B Brewer
Journal:  Neurobiol Aging       Date:  2021-06-04       Impact factor: 5.133

4.  CSF Alzheimer Disease Biomarkers: Time-Varying Relationships With MCI Symptom Onset and Associations With Age, Sex, and ApoE4.

Authors:  Barry D Greenberg; Corinne Pettigrew; Anja Soldan; Jiangxia Wang; Mei-Cheng Wang; Jacqueline A Darrow; Marilyn S Albert; Abhay Moghekar
Journal:  Neurology       Date:  2022-10-11       Impact factor: 11.800

Review 5.  2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer's disease in the context of a structured 5-phase development framework.

Authors:  A Leuzy; N J Ashton; N Mattsson-Carlgren; A Dodich; M Boccardi; J Corre; A Drzezga; A Nordberg; R Ossenkoppele; H Zetterberg; K Blennow; G B Frisoni; V Garibotto; O Hansson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-03-05       Impact factor: 9.236

6.  Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.

Authors:  Gemma Salvadó; Michel J Grothe; Colin Groot; Alexis Moscoso; Michael Schöll; Juan Domingo Gispert; Rik Ossenkoppele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-02-01       Impact factor: 9.236

7.  The Associations of Cerebrospinal Fluid ApoE and Biomarkers of Alzheimer's Disease: Exploring Interactions With Sex.

Authors:  Ying Liu; Jing-Hui Song; Wei Xu; Xiao-He Hou; Jie-Qiong Li; Jin-Tai Yu; Lan Tan; Song Chi
Journal:  Front Neurosci       Date:  2021-03-03       Impact factor: 4.677

8.  Inflammatory cytokine levels implicated in Alzheimer's disease moderate the effects of sex on verbal memory performance.

Authors:  Jessica Z K Caldwell; Jefferson W Kinney; Aaron Ritter; Arnold Salazar; Christina G Wong; Dietmar Cordes; George M Slavich
Journal:  Brain Behav Immun       Date:  2020-12-08       Impact factor: 19.227

9.  Sex Mediates Relationships Between Regional Tau Pathology and Cognitive Decline.

Authors:  Rachel F Buckley; Matthew R Scott; Heidi I L Jacobs; Aaron P Schultz; Michael J Properzi; Rebecca E Amariglio; Timothy J Hohman; Danielle V Mayblyum; Zoe B Rubinstein; Lyssa Manning; Bernard J Hanseeuw; Elizabeth C Mormino; Dorene M Rentz; Keith A Johnson; Reisa A Sperling
Journal:  Ann Neurol       Date:  2020-08-31       Impact factor: 10.422

Review 10.  The human connectome in Alzheimer disease - relationship to biomarkers and genetics.

Authors:  Meichen Yu; Olaf Sporns; Andrew J Saykin
Journal:  Nat Rev Neurol       Date:  2021-07-20       Impact factor: 44.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.